ArticlePreventive medicine2026
The dual use dilemma: Is it better to have tried and failed to quit smoking with e-cigarettes or to have never tried e-cigarettes at all?
Article in Preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
E-cigarettes are an effective way to stop smoking but there is disagreement regarding their use as treatment. One concern is that recommending e-cigarettes for adults who smoke (AWS) could result in sustained dual use of both products among those who fail to quit smoking. Given most quit attempts end in failure, it is important to understand the likelihood of developing dual use and its consequences when considering e-cigarettes for AWS. We describe variability in dual use within a behavioral economics framework, including literature which addresses the likelihood that trying to quit smoking with e-cigarettes will lead to established dual use as well as the impact that dual use has on smoking heaviness and smoking cessation. Limited evidence suggests that a meaningful minority of AWS who initiate e-cigarettes with support to quit smoking establish dual use. Compared to exclusive smoking, dual use appears to be associated with an overall reduction in smoking and an increase in the likelihood of cessation. However, outcomes appear to vary based on substitutive versus complementary use patterns, with the potential for dual use to lead to sustained or increased smoking for a small proportion of AWS who initiate e-cigarettes. Compared to exclusive smoking, developing dual use is likely associated with reduced smoking for the majority of AWS, providing further support for including e-cigarettes as a smoking cessation treatment option. Future prospective and controlled research is needed to explore predictors of developing substitutive versus complementary patterns of dual use and subsequent smoking cessation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.